Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
Clinical trial NCT05485909 · UNKNOWN
Trial details
- NCT number
- NCT05485909
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-25
- Primary completion
- 2023-07-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.